FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of therapeutic ultrasonic medical device technology for the treatment of cancer and other acute or chronic health conditions, today announced that its management will present at the Jesup & Lamont Emerging Growth Stock Conference on Thursday, February 28, 2008, which will be held at the Disney Contemporary Resort in Orlando, Florida.
